News
Shorter antibiotic course treats periotoneal infections
Major finding: In patients with intraabdominal infections, the rates of a composite of adverse outcomes were similar – about 22% – after a 4-day...
News
TAVR beat surgery in high-risk aortic stenosis patients
Major finding: All-cause mortality was 14.2% among high-risk patients with severe aortic stenosis 1 year after TAVR with a self-expanding aortic...
News
Canagliflozin effects include weight loss in phase III placebo-controlled trial
Major finding: In addition to significant reductions in HbA1c after 26 weeks of treatment with canagliflozin over placebo, treatment resulted in a...
News
20-study analysis finds no MACE increase with saxagliptin
Major finding: The incidence of MACE composite endpoint was similar among patients treated with saxagliptin (0.85/100 person-years) and controls (...
News
Empagliflozin improves glycemia, blood pressure in type 2 diabetes study
Key clinical point: A treatment approach that includes control of blood pressure and hyperglycemia might reduce the risk of cardiovascular...
News
UPDATED: FDA-released safety data on dabigatran vs. warfarin reassuring
Major finding: The risks of ischemic stroke, intracranial hemorrhage, and death associated with dabigatran treatment were lower than with warfarin...
News
Hypoalbuminemia linked to increased surgical risks in obese patients
Key clinical point: Carefully evaluate protein deficiency in obese patients before surgery.Major finding: In hypoalbuminemic patients with a BMI...
News
FDA approves first-in-class oral antiplatelet drug vorapaxar
The novel antiplatelet drug vorapaxar has been approved for reducing the risk of myocardial infarction, stroke, cardiovascular death, and need for...
